UNSPSC 51373200: Controlled substance analgesic phenols

Controlled substance analgesics based on organic compounds composed of a six-membered ring containing two nitrogen atoms at opposite positions (hexa-hydro-pyrazine(s)).

UNSPSC 51373200 Controlled substance analgesic phenols is a Class code covering pharmaceuticals and related health products that state and local governments procure for public health, emergency response, and community health initiatives. The code encompasses naloxone, opioid antagonists, pain-management pharmaceuticals, and drug deactivation or disposal systems used by county health departments, state health agencies, and municipalities to address substance abuse and emergency medical response. Recent solicitations show state and local buyers acquiring naloxone in bulk quantities with scheduled quarterly or standing deliveries, generic pharmaceutical products through cooperative purchasing arrangements with authorized wholesalers, and companion products like drug deactivation systems that support harm-reduction and substance-abuse treatment programs.

Issuing bodies include county health departments (Seminole County, Florida), state health and human services agencies (Texas Health and Human Services Commission), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, serving participating states and local facilities including Oregon). Geographic activity centers on Florida, Texas, and Minnesota, with cooperative purchasing extending across multiple jurisdictions. Representative recent opportunities include Seminole County's IFB 60459723LAS for 1,900 units of naloxone and 800 safe drug deactivation systems annually with a July 26, 2023 response deadline; Texas HHS Commission's RFI HHS0017013 (posted April 3, 2026) seeking vendor capabilities for direct-to-manufacturer prescription programs; and MMCAP's RFP S1070000015802 (due March 26, 2026) to establish multiple contracts for generic multi-source pharmaceuticals and OTC products distributed through three authorized wholesalers across participating government facilities. Vendors must typically certify Drug Supply Chain Security Act (DSCSA) compliance, maintain cGMP standards, demonstrate pricing flexibility through multiple net-price formats, and carry commercial general liability insurance of $2 million to $5 million per occurrence.